医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Theorem Clinical Research Expands Leadership and Prepares for Growth with Addition of Kathryn Bohannon and Angela Weston

2014年11月05日 PM10:00
このエントリーをはてなブックマークに追加


 

KING OF PRUSSIA, Pa.

Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, has named Kathryn Bohannon as vice president of biopharmaceutical development and Angela Weston as vice president of business development in Europe and Asia.

Bohannon increases Theorem’s scientific and medical leadership in pediatrics and rare disease with almost 20 years of diverse pharmaceutical research and development experience, including Phase I-IV clinical research, laboratory research and development as well as U.S. and global project management and direct sales and marketing. She has developed and managed projects across multiple therapeutic areas and clinical settings, including the Best Pharmaceuticals for Children Act – Data Coordinating Center within the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Weston brings more than 20 years of experience to Theorem, spanning a broad range of commercial disciplines in the pharmaceutical, biotech and medical device industries. She has worked extensively in business development, previously serving as senior vice president for business development at a global clinical contract research organization. In this role, she organized and managed the pharmaceutical, medical device and clinical resource sales teams. Additionally, Weston is a clinical nurse specialist and paramedic.

“These professionals further enhance our capabilities and client services,” said John Potthoff, Theorem president and CEO. “We have the right experts in place to provide meaningful expertise in key aspects of clinical trials.”

Learn more about Theorem, its services and therapeutic areas of expertise at www.theoremclinical.com.

About Theorem Clinical Research

Theorem Clinical Research is a global provider of comprehensive clinical services with staff throughout the Americas, Europe and Asia and a client base comprised of the world’s leading biopharmaceutical and medical device companies. With industry-leading experts, unparalleled therapeutic expertise and innovative technology, Theorem is focused on analytic-based development, combination trials and personal data applications to simplify complex trials.

CONTACT

SCORR Marketing
Lea Studer, +1-308-237-5567
lea@scorrmarketing.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates
  • Exome-Backed Broncus Holding Corporation Launches Hong Kong Public Offering
  • Saladax Biomedical宣布Salvatore J. Salamone博士荣获著名的C.E. Pippenger博士奖
  • IHMA在上海建立微生物学参考实验室,进一步支持全球抗感染产品的发现和开发
  • Rhizen Pharmaceuticals AG宣布,RP7214治疗新冠肺炎患者2期研究进行首例患者给药